ISRCTN57744970已完成未知
A prospective, randomised, double-blind, placebo-controlled trial evaluating the effects of mycophenolate mofetil (MMF) on surrogate markers for atherosclerosis in female patients with systemic lupus erythematosus
Guy's and St Thomas' NHS Foundation Trust (UK)0 个研究点目标入组 100 人开始时间: 2006年4月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Female systemic lupus erythematosus (SLE) patients
- •2. Age 18-50 years
- •3. Pre-menopausal, using a reliable method of contraception
- •4. Clinically stable disease
- •5. Taking hydroxychloroquine, prednisolone up to 15 mg per day or both
排除标准
- •1. Smokers
- •2. Pregnant or breast-feeding
- •3. Use of other immunosuppressants
- •4. Use of any investigational drug within one month prior to screening
- •5. Acute infections two weeks prior to visit
- •6. History of ischaemic heart disease or end stage renal failure
- •7. Current signs of severe hepatic, gastrointestinal, endocrine, pulmonary, cardiac or neurological disease
研究者
相似试验
进行中（未招募）
1 期
A prospective, randomised, double-blind, placebo-controlled, parallel group dose ranging study in asthma patients in Iceland to assess the safety, tolerability and efficacy of the MLK inhibitor, CEP-1347AsthmaEUCTR2004-002812-27-ISdeCODE genetics ehf.160
已完成
不适用
A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patientsISRCTN30198912Record Provided by the NHSTCT Register - 2007 Update - Department of Health60
进行中（未招募）
1 期
A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patients - randomised, double-blind, placebo-controlled,respiratory effects, oxycodone, morphineEUCTR2006-003302-25-GBBarts and The London NHS Trust
进行中（未招募）
不适用
A prospective, randomised, double-blind, placebo-controlled, parallel-group, international multicentre phase III trial of PI-88 in the adjuvant treatment of post-resection hepatocellular carcinomaEstudio Fase III, internacional, multicéntrico, prospectivo, aleatorizado, doble-ciego y controlado con placebo, de grupos paralelos de PI-88 en el tratamiento adyuvante de carcinoma hepatocelular post-resección (Pathway) - PATHWAYpost-resection hepatocellular carcinomaCarcinoma hepatocelular post-resecciónMedDRA version: 9.1Level: LLTClassification code 10019830Term: Hepatocellular carcinoma resectableEUCTR2007-005011-25-ESProgen Pharmaceuticals Limited600
进行中（未招募）
1 期
A prospective, double-blind, randomised, placebo-controlled trial on the efficacy and safety of Neiromidin 20 mg tablets in the treatment of patients with lumbosacral radiculopathyumbosacral radiculopathyEUCTR2019-002632-90-PLOlainfarm AS458